DENVER, CO,
April 7 /PRNewswire/ - Medical
International Technology Inc. (OTCBB: MDLH) www.mitneedlefree.com
is pleased to announce its latest achievements in Russia.
Over the past few months, MIT has been working closely with a Russian
distributor to cover its marketing and sales in Russia. The newly signed distributor agreement
and initial order worth approximately half-a-million dollars in
Med-Jet products for the mesotherapy market is in progress.
Mr Karim Menassa
was in Moscow for a sales and
marketing kick off meeting to launch the Med-Jet products into the
lucrative cosmetic market. The meeting was organized by
MIT's Russian distributor and held at a
prestigious Moscow hotel in the
presence of over 300 specialists, in addition to Canadian
dignitaries and local and international media.
MIT is delighted to
have received the official certification to sell
MED-JET® products to a very important market, said
MIT President and CEO, Mr Karim Menassa. This new distributor will help
MIT Canada achieve its business plan, which forecasts multi-million
dollars of sales in different niche markets worldwide within the
next 3 to 5 years.
Dr. Francis
Bellido, Vice-President and Chief Strategy Officer of
MIT Canada believes that the access to
the fast growing Russian cosmetic market is a tremendous
achievement and will serve to open future markets around the world
to MIT's unique and effective products
and technologies.
Medical International Technology Inc. is proud
to continue providing a safe and effective means to help prevent
the spread of deadly diseases to both humans and animals through
the use of the Med-Jet® and Agro-Jet®
needle-free injection system.
About Medical International Technology, Inc. MIT
CANADA, with offices in
Montreal, is a subsidiary of
Denver, Colorado-based Medical
International Technology, Inc. (MIT USA), which specializes in the
development, production, marketing and sale of needle-free
injectors both for humans and animals, for individual and mass
vaccinations.
The statements which are not historical facts
contained in this press release are forward-looking statements that
involve certain risks and uncertainties, including but not limited
to risks associated with the uncertainty of future financial
results, additional financing requirements, development and
acquisition of new product lines and services, government approval
processes, the impact of competitive products or pricing a
technological changes, the effect of economic conditions and other
uncertainties, and the risk factors set forth from time to time in
the Company's SEC reports, including but not limited to its annual
report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and
any reports on Form 8-K. Medical International Technology Inc.
takes no obligation to update or correct forward-looking
statements.
SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.
